RecruitingNot ApplicableNCT04748237

Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients

Randomized Evaluation of Coronary Computed Tomographic Angiography in Intermediate-risk Patients Presenting to the Emergency Department With Chest Pain


Sponsor

Karolinska Institutet

Enrollment

1,600 participants

Start Date

Jan 21, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The aim is to determine whether a diagnostic strategy including early coronary computed tomographic angiography in intermediate-risk patients presenting to the Emergency Department with chest pain reduces the composite endpoint of death, readmission because of myocardial infarction or unstable angina requiring revascularization.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age≥18 years.
  • Within 24 hours from presenting to the ED with chest pain or other symptoms suggestive of coronary artery disease (CAD)
  • HEART-score >3 (according to http://www.heartscore.nl/)
  • Written informed consent obtained

Exclusion Criteria11

  • Any condition that may influence the patient's ability to comply with study protocol.
  • Acute MI
  • Known obstructive CAD (>50%) or previous PCI or CABG.
  • Clear alternative diagnosis
  • Estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73m2
  • Major allergy to iodinated contrast media
  • Circumstances making high quality images unlikely.
  • Not a Swedish resident with a personal ID-number.
  • Pregnancy or breast feeding
  • Further investigation for CAD not indicated, due to limited life expectancy, quality of life or functional status
  • Previous inclusion in the trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCoronary computed tomopraphic angiography

CCTA as soon as possible, preferably within 24 hours, but not later than within 21 days.


Locations(1)

Danderyd Hospital

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04748237


Related Trials